Breast cancer Page
[…] PDX models are created by transplanting human tumour tissue into immunodeficient mice. Our collection of breast cancer PDX models includes those from patients affected by the most advanced and lethal forms of breast […]
Bridging the translational gap: How PDX models are transforming breast cancer research, drug discovery and precision oncology Blog Post
[…] her own laboratory at the University of Utah’s Huntsman Cancer Institute and began developing novel breast cancer PDX models. These spanned different breast cancer types. Her research focuses on solving the problem of […]
HCI-016 breast cancer PDX Product
HCI-016 PDX: Sample collected in 2013 from breast tumour of Caucasian female, age 93 at time of collection with a primary diagnosis of IDC;2013.
HCI-008 breast cancer PDX Product
HCI-008 PDX: Sample collected from pleural effusion of Caucasian female, age 87 with a primary diagnosis of inflammatory breast cancer (2007).
HCI-028 breast cancer PDX Product
HCI-028 PDX: One of many Patient Derived Xenografts providing breast cancer models including endocrine-resistant estrogen receptor-positive (ER+).
HCI-048 breast cancer PDX Product
HCI-048 PDX model for breast cancer including metastatic tumours, and endocrine-resistant estrogen receptor-positive (ER+) and HER2+ tumours.
HCI-045 breast cancer PDX Product
HCI-045 PDX – Part of a panel of Patient Derived Xenografts providing models for breast cancer including drug-resistant and metastatic tumours.
HCI-017 breast cancer PDX Product
HCI-017 PDX: One of many Patient Derived Xenografts providing models for breast cancer including drug-resistant, metastatic tumours, and HER2+ tumours.
HCI-004 breast cancer PDX Product
HCI-004 PDX: One of many Patient Derived Xenografts providing models for some of the deadliest forms of breast cancer including drug-resistant.
HCI-003 breast cancer PDX Product
HCI-003 PDX: One of many Patient Derived Xenografts providing breast cancer models including endocrine-resistant estrogen receptor-positive (ER+).
